Found 18 matching trials
The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients PHASE3 This is a 28-week, multi-center, randomized, double-blind, placebo-controll...
Show More Location
Diabeteszentrum Oldenburg
Learn More & Join Trial
A Long-term Trial to Compare the Effects of Liraglutide and Sulphonylurea (Glimepiride) Both in Combination With Metformin on Clinical, Endothelial and Image Markers of Cardiovascular Risk in Patients With Type 2 Diabetes PHASE4 The process of atherosclerosis is multifactorial and involves many mechanis...
Show More Location
Hospital Clínico San Carlos
Learn More & Join Trial
Randomized Controlled Trial of Insulin Versus Tablets for Latent Autoimmune Diabetes in Adults (LADA) NA Background: Latent autoimmune diabetes in adults \[LADA\] is a type 1 diabe...
Show More Learn More & Join Trial
Endotherapy for Painless Chronic Pancreatitis NA This is a prospective randomized controlled trial. . Patients will be divid...
Show More Location
Changhai Hospital
Learn More & Join Trial
Glycaemic & Cardiovascular Treatment Outcomes of Voglibose Vs Glibenclamide Added to Metformin in T2DM Patients PHASE3 The goal of this clinical trial is to compare blood-sugar control and blood...
Show More Location
Multiple Locations
Learn More & Join Trial
Liraglutide Effect in Atrial Fibrillation PHASE4 The goal (or purpose) of this study is to evaluate (study) a new way to sta...
Show More Status
Active Not Recruiting
Location
University of Miami
Learn More & Join Trial
Efficacy and Safety Comparison of Metformin/Glimepiride Combination Versus Each Compound Alone in New Diagnosed Type 2 Diabetes Patients PHASE3 Primary Objective:
\- To demonstrate the superiority of glimepiride and me...
Show More Location
Investigational Site Number 01206
Learn More & Join Trial
Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes PHASE4 High blood glucose levels in hospitalized patients with diabetes are associ...
Show More Location
Grady Memorial Hospital
Learn More & Join Trial
Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period PHASE3 Primary Objective:
To demonstrate the superiority of the insulin glargine/...
Show More Location
Investigational Site Number 8400064
Learn More & Join Trial
Efficacy and Safety of Hebenrun in Patients With Type 2 Diabetes NA This study aims to evaluate the efficacy and safety of Hebenrun (a function...
Show More Location
The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine
Learn More & Join Trial